Clinical trial
Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed…
NCT00476177 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00476177 |
|---|---|
| Title | Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant |
| Official title | Infusion of Donor Dendritic Cells and Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogenic Transplant |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Beth Israel Deaconess Medical Center National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hematologic Malignancy |
| Intervention type | Biological |
| Interventions | Infusion of donor dendritic cells, Infusion of donor lymphocytes |
| Enrollment | 25 |
| Start date | Jul 1, 2003 |
| Primary completion | Aug 1, 2007 |
| Completion | Jul 1, 2009 |
| First posted | May 21, 2007 |
| Last update posted | Mar 29, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: